384 related articles for article (PubMed ID: 38473934)
1. Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.
Yang M; Zhu L
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473934
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism.
Andreev D; Kachler K; Schett G; Bozec A
Bone; 2022 Sep; 162():116468. PubMed ID: 35688359
[TBL] [Abstract][Full Text] [Related]
3. Clinical immunity in bone and joints.
Tanaka Y
J Bone Miner Metab; 2019 Jan; 37(1):2-8. PubMed ID: 30324535
[TBL] [Abstract][Full Text] [Related]
4. Immune-bone interplay in the structural damage in rheumatoid arthritis.
Komatsu N; Takayanagi H
Clin Exp Immunol; 2018 Oct; 194(1):1-8. PubMed ID: 30022480
[TBL] [Abstract][Full Text] [Related]
5. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mediated bone destruction in rheumatoid arthritis.
Jung SM; Kim KW; Yang CW; Park SH; Ju JH
J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
[TBL] [Abstract][Full Text] [Related]
7. Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors.
Hu L; Liu R; Zhang L
Int Immunopharmacol; 2022 Oct; 111():109095. PubMed ID: 35926270
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.
Komatsu N; Takayanagi H
Nat Rev Rheumatol; 2022 Jul; 18(7):415-429. PubMed ID: 35705856
[TBL] [Abstract][Full Text] [Related]
9. Bone destruction in arthritis.
Gravallese EM
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system.
Tanaka Y; Ohira T
Curr Opin Pharmacol; 2018 Jun; 40():110-119. PubMed ID: 29702364
[TBL] [Abstract][Full Text] [Related]
11. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
12. RANKL: A therapeutic target for bone destruction in rheumatoid arthritis.
Tanaka S; Tanaka Y; Ishiguro N; Yamanaka H; Takeuchi T
Mod Rheumatol; 2018 Jan; 28(1):9-16. PubMed ID: 28880683
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis.
Matsuda K; Shiba N; Hiraoka K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982247
[TBL] [Abstract][Full Text] [Related]
14. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
[TBL] [Abstract][Full Text] [Related]
16. RANKL is a therapeutic target of bone destruction in rheumatoid arthritis.
Tanaka S
F1000Res; 2019; 8():. PubMed ID: 31069051
[TBL] [Abstract][Full Text] [Related]
17. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis.
Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW
J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535
[TBL] [Abstract][Full Text] [Related]
18. Osteoimmunology and the effects of the immune system on bone.
Takayanagi H
Nat Rev Rheumatol; 2009 Dec; 5(12):667-76. PubMed ID: 19884898
[TBL] [Abstract][Full Text] [Related]
19. Osteoclasts in arthritis and Th17 cell development.
Okamoto K; Takayanagi H
Int Immunopharmacol; 2011 May; 11(5):543-8. PubMed ID: 21081190
[TBL] [Abstract][Full Text] [Related]
20. Promising bone-related therapeutic targets for rheumatoid arthritis.
Choi Y; Arron JR; Townsend MJ
Nat Rev Rheumatol; 2009 Oct; 5(10):543-8. PubMed ID: 19798028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
